Nucleic acid-based theranostics in type 1 diabetes

Application of RNAi interference for type 1 diabetes (T1D) therapy bears tremendous potential. This review will discuss vehicles for oligonucleotide delivery, imaging modalities used for delivery monitoring, therapeutic targets, and different theranostic strategies that can be applied for T1D treatment.

Source: Translational Research - August 20, 2019 Category: Research Authors: Bennett Francis Dwan, Anna Moore, Ping Wang Tags: Review Article Source Type: research